The role of percutaneous biopsy in detection of pancreatic transplant rejection

2000 ◽  
Vol 14 (5) ◽  
pp. 493-498 ◽  
Author(s):  
Brett C Lee ◽  
John P McGahan ◽  
Richard V Perez ◽  
John M Boone
Keyword(s):  
Transplant Rejection ◽  
Percutaneous Biopsy ◽  
Pancreatic Transplant

Diagnostic pancreatic cancer: the role of percutaneous biopsy and CT

2007 ◽  
Vol 31 (3) ◽  
pp. 221
Author(s):  
Z. Amin ◽  
B. Theis ◽  
R.C.G. Russell ◽  
C. House ◽  
M. Novelli ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Percutaneous Biopsy

Pancreatic transplant rejection: assessment with duplex US.

Radiology ◽  
1989 ◽  
Vol 173 (1) ◽  
pp. 131-135 ◽  
Author(s):  
B Patel ◽  
M K Wolverson ◽  
B Mahanta
Keyword(s):  
Transplant Rejection ◽  
Pancreatic Transplant

Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection

2004 ◽  
Vol 286 (6) ◽  
pp. L1129-L1139 ◽  
Author(s):  
Tina L. Sumpter ◽  
David S. Wilkes
Keyword(s):  
Lung Transplantation ◽  
Lung Transplant ◽  
Transplant Rejection ◽  
Survival Rates ◽  
Definitive Treatment ◽  
Solid Organ ◽  
Type V Collagen ◽  
End Stage ◽  
Type V

Lung transplantation is the only definitive treatment modality for many forms of end-stage lung disease. However, the lung is rejected more often than any other type of solid organ allograft due to chronic rejection known as bronchiolitis obliterans (BO). Indeed, BO is the primary reason why the 5- and 7-yr survival rates are worse for the lung than for any other transplanted organ. Alloimmunity to donor antigens is established as the primary mechanism that mediates rejection responses. However, newer immunosuppressive regimens designed to abrogate alloimmune activation have not improved survival. Therefore, these data suggest that other antigens, unrelated to donor transplantation antigens, are involved in rejection. Utilizing human and rodent studies of lung transplantation, our laboratory has documented that a native collagen, type V collagen [col(V)], is a target of the rejection response. Col(V) is highly conserved; therefore, these data indicate that transplant rejection involves both alloimmune and autoimmune responses. The role of col(V) in lung transplant rejection is described in this review article. In addition, the potential role of regulatory T cells that are crucial to modulating autoimmunity and alloimmunity is also discussed.

scholarly journals The role of complement in antibody mediated transplant rejection

2019 ◽  
Vol 112 ◽  
pp. 240-246 ◽  
Author(s):  
Joshua M. Thurman ◽  
Sarah E. Panzer ◽  
Moglie Le Quintrec
Keyword(s):  
Transplant Rejection

The Role of Macrophages in Transplant Rejection

2012 ◽  
Vol 26 (3) ◽  
pp. 165
Author(s):  
Hye-Jung Yeom ◽  
Curie Ahn ◽  
Jaeseok Yang
Keyword(s):  
Transplant Rejection

scholarly journals Role of Th17 cells and IL-17 in lung transplant rejection

2011 ◽  
Vol 33 (2) ◽  
pp. 129-134 ◽  
Author(s):  
Rebecca A. Shilling ◽  
David S. Wilkes
Keyword(s):  
Th17 Cells ◽  
Lung Transplant ◽  
Transplant Rejection

Met-RANTES Inhibition of Mucosal Perfusion Failure in Acute Intestinal Transplant Rejection – Role of Endothelial Cell-Leukocyte Interaction

2002 ◽  
Vol 39 (1) ◽  
pp. 51-58 ◽  
Author(s):  
Tomislav Stojanovic ◽  
Jens Bedke ◽  
Hermann-Josef Gröne ◽  
Amanda E.I. Proudfoot ◽  
Heinz Becker ◽  
...  
Keyword(s):  
Endothelial Cell ◽  
Transplant Rejection ◽  
Perfusion Failure ◽  
Mucosal Perfusion ◽  
Intestinal Transplant
Sign in / Sign up

Export Citation Format

Share Document